Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,500
Closed -$429K 758
2023
Q3
$429K Sell
1,500
-15,700
-91% -$4.48M 0.01% 504
2023
Q2
$4.83M Sell
17,200
-7,700
-31% -$2.01M 0.17% 105
2023
Q1
$6.36M Buy
+24,900
New +$7.26M 0.22% 75
2022
Q4
Sell
-10,400
Closed -$2.89M 950
2022
Q3
$2.89M Buy
+10,400
New +$2.93M 0.13% 137
2020
Q1
Sell
-7,200
Closed -$1.47M 1357
2019
Q4
$1.47M Buy
+7,200
New +$1.32M 0.02% 751
2018
Q4
Sell
-10,200
Closed -$2.12M 1329
2018
Q3
$2.12M Sell
10,200
-35,200
-78% -$6.53M 0.04% 430
2018
Q2
$7.72M Buy
+45,400
New +$7.86M 0.14% 109
2018
Q1
Sell
-21,000
Closed -$4.26M 1981
2017
Q4
$4.26M Hold
21,000
0.06% 327
2017
Q3
$3.93M Hold
21,000
0.05% 363
2017
Q2
$3.52M Sell
21,000
-1,500
-7% -$241K 0.04% 449
2017
Q1
$3.3M Buy
+22,500
New +$3.32M 0.04% 500
2016
Q4
Sell
-20,000
Closed -$2.61M 1988
2016
Q3
$2.61M Hold
20,000
0.03% 420
2016
Q2
$2.56M Hold
20,000
0.03% 560
2016
Q1
$2.75M Sell
20,000
-33,400
-63% -$4.59M 0.05% 361
2015
Q4
$7.81M Buy
53,400
+17,100
+47% +$2.35M 0.21% 73
2015
Q3
$4.9M Sell
36,300
-40,900
-53% -$5.94M 0.11% 114
2015
Q2
$12.5M Buy
77,200
+31,500
+69% +$4.35M 0.24% 88
2015
Q1
$5.92M Sell
45,700
-17,400
-28% -$2.02M 0.17% 108
2014
Q4
$6.49M Buy
+63,100
New +$6.22M 0.28% 72

Other funds holding CI

Paloma Partners's CI Position: Q4 2024 in Review

Paloma Partners sold out of Cigna (CI) in Q4 2024, closing a stake of 2,364 shares — an estimated $819K sold.

Paloma Partners first reported a position in CI in Q2 2013 and held it in 40 quarters. The position peaked at $18.8M in Q2 2021. 1,646 funds tracked by Wall St. Rank hold CI as of Q4 2024.

  • Paloma Partners reported no remaining Cigna position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 2,364 Cigna shares in Q4 2024, an estimated $819K.
  • Paloma Partners first reported a position in Cigna in Q2 2013 and held it in 40 quarters.
  • Paloma Partners's Cigna position peaked at $18.8M in Q2 2021.
  • 1,646 funds tracked by Wall St. Rank held Cigna as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.